Journal

Latest articles

Field notes, product thinking, and practical guidance from the Phramagica team.

Showing 1 - 2 of 2 Posts

1 min read05/07/2026

test

Clinical Trials

1 min read01/05/2026

Immunotherapy for Alzheimer's Disease: Phase II Trial Results

Anti-tau antibody reduces cognitive decline by 54% in early-stage patients